6
Oct
2026
Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026
stand 16C74
Book a meeting

AMW

  • AMW GmbH Headquarters
  • Biodegradable implants
  • AMW´s implants releasing goserelin or leuprorelin
  • AMW offers various partnering opportunities
About AMW

AMW GmbH is a specialty pharmaceutical company focused on biodegradable implants, providing value-added medicines for improved adherence and cost-effective therapies. The Company covers the entire value chain, from (co-)development to manufacturing and international commercialization.

AMW has three pharmaceutical products on the market: implants releasing goserelin or leuprorelin respectively, which are distributed in numerous markets via direct sales and out-licensing. Based on its unparalleled expertise in formulation development, the Company collaborates with pharma and biotech partners worldwide to develop and manufacture high-quality products and life-cycle solu...

Read more Show less
Certifications
  • GMP
    GMP
  • ISO
    ISO
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less

Meet us at

  • CPHI Milan 2026

    CPHI Milan 2026

    Fiera Milano, Italy
    6 Oct 2026 - 8 Oct 2026
    stand 16C74
  • Country/Region:
    Germany
  • On CPHI since:
    2021
  • Certificates:
    2
  • Employees:
    100 - 249
Company types
CMO/CDMO
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Contract Manufacturer
Contract Research Organisation
Out-licensing specialist
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
Technology
Contact info
Show contact info Hide contact info

Products from AMW (3)

  • Goserelin 10,8mg (3 months) - implant in a pre-filled syringe

    Product Goserelin 10,8mg (3 months) - implant in a pre-filled syringe

    The active ingredient goserelin is a synthetic peptide that can be used primarily in the treatment of hormone-dependent tumors, particularly prostate cancer. Thus, goserelin intake has indirect effects on testosterone levels in men, the lowering of which stops the growth of malignant cancerous tumors. In a...
  • Goserelin 3,6mg (1 month) - implant in a pre-filled syringe

    Product Goserelin 3,6mg (1 month) - implant in a pre-filled syringe

    The active ingredient goserelin is a synthetic peptide that can be used primarily in the treatment of hormone-dependent tumors, particularly prostate cancer. Thus, goserelin intake has indirect effects on testosterone levels in men, the lowering of which stops the growth of malignant cancerous tumors. In a...
  • Leuproreline actetate 11.25 mg (3 months) - implant in a pre-filled syringe

    Product Leuproreline actetate 11.25 mg (3 months) - implant in a pre-filled syringe

    The active ingredient leuprorelin, is a synthetic peptide that can be used primarily in the treatment of hormone-dependent tumors, particularly prostate cancer. Administration of leuprorelin has indirect effects on testosterone levels in men, the lowering of which stops the growth of malignant cancerous tu...

AMW Resources (1)